BioCentury | Oct 4, 2010
Financial News

Agennix completes rights offering

...$105.6 million) Shares: 20.6 million Price: €3.81 Shares after offering: 41.3 million Underwriters: Piper Jaffray; WestLB...
BioCentury | Oct 1, 2010
Top Story

Agennix raises EUR 78.4 million

...by shareholder dievini Hopp BioTech. dievini Hopp now holds 59% of Agennix. Piper Jaffray and WestLB...
BioCentury | Sep 20, 2010
Finance

Recapping Agennix

...Talactoferrin is a recombinant human lactoferrin (rhLF) dendritic cell recruiter and activator. Piper Jaffray and WestLB...
BioCentury | Sep 20, 2010
Financial News

Agennix proposes rights offering

...raised: Up to €78.4 million ($100.5 million) Shares: 20.6 million Price: €3.81 Underwriters: Piper Jaffray; WestLB...
BioCentury | Sep 16, 2010
Financial News

Agennix planning rights issue

...not subscribed or sold in the private placement to purchase in shares. Piper Jaffray and WestLB...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...Alta Berkeley Associates; Alta Partners; Domain Associates; IKB; Julius Baer; Merlin Biosciences; Techno-Venture; Viscardi GmbH; WestLB...
...Alta Berkeley Associates; Alta Partners; Life Science Venture Fund; Merlin Biosciences; TVM Capital; Viscardi GmbH; WestLB...
BioCentury | Nov 11, 2006
Top Story

LifeCycle, Wilex price IPOs

...proposed EUR 13.80-EUR 15.80 range and values the company at EUR 165 million ($209.8 million). WestLB...
BioCentury | Nov 7, 2006
Financial News

Wilex updates IPO plans

...59.2 million ($75.3 million) and have a post-money valuation of EUR 177 million ($225.1 million). WestLB...
BioCentury | Nov 4, 2006
Financial News

Santhera prices IPO

...million ($66.4-$78.2 million). Deutsche Bank acted as global coordinator and lead manager, while Piper Jaffray; WestLB...
BioCentury | Oct 30, 2006
Finance

Ebb & Flow

...Nov. 3. Deutsche Bank is global coordinator and lead manager. Other underwriters include Piper Jaffray; WestLB...
Items per page:
1 - 10 of 70
BioCentury | Oct 4, 2010
Financial News

Agennix completes rights offering

...$105.6 million) Shares: 20.6 million Price: €3.81 Shares after offering: 41.3 million Underwriters: Piper Jaffray; WestLB...
BioCentury | Oct 1, 2010
Top Story

Agennix raises EUR 78.4 million

...by shareholder dievini Hopp BioTech. dievini Hopp now holds 59% of Agennix. Piper Jaffray and WestLB...
BioCentury | Sep 20, 2010
Finance

Recapping Agennix

...Talactoferrin is a recombinant human lactoferrin (rhLF) dendritic cell recruiter and activator. Piper Jaffray and WestLB...
BioCentury | Sep 20, 2010
Financial News

Agennix proposes rights offering

...raised: Up to €78.4 million ($100.5 million) Shares: 20.6 million Price: €3.81 Underwriters: Piper Jaffray; WestLB...
BioCentury | Sep 16, 2010
Financial News

Agennix planning rights issue

...not subscribed or sold in the private placement to purchase in shares. Piper Jaffray and WestLB...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...Alta Berkeley Associates; Alta Partners; Domain Associates; IKB; Julius Baer; Merlin Biosciences; Techno-Venture; Viscardi GmbH; WestLB...
...Alta Berkeley Associates; Alta Partners; Life Science Venture Fund; Merlin Biosciences; TVM Capital; Viscardi GmbH; WestLB...
BioCentury | Nov 11, 2006
Top Story

LifeCycle, Wilex price IPOs

...proposed EUR 13.80-EUR 15.80 range and values the company at EUR 165 million ($209.8 million). WestLB...
BioCentury | Nov 7, 2006
Financial News

Wilex updates IPO plans

...59.2 million ($75.3 million) and have a post-money valuation of EUR 177 million ($225.1 million). WestLB...
BioCentury | Nov 4, 2006
Financial News

Santhera prices IPO

...million ($66.4-$78.2 million). Deutsche Bank acted as global coordinator and lead manager, while Piper Jaffray; WestLB...
BioCentury | Oct 30, 2006
Finance

Ebb & Flow

...Nov. 3. Deutsche Bank is global coordinator and lead manager. Other underwriters include Piper Jaffray; WestLB...
Items per page:
1 - 10 of 70